|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Post-Transplant, Epstein-Barr Virus DNA, Quantitative Real-Time PCR, Plasma
Test Code18089
CPT Codes
87799
Preferred Specimen
1 mL plasma collected in an EDTA (lavender-top) tube
Minimum Volume
0.5 mL
Instructions
For Shipper collection please see detailed instructions in Test Resources
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 8 days
Frozen: 30 days
Refrigerated: 8 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Samples collected in sodium or lithium heparin
Methodology
Real-Time Polymerase Chain Reaction
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 1 day
Reference Range
EBV DNA, QN PCR | Not Detected (copies/mL) |
EBV DNA, QN PCR | Not Detected (Log copies/mL) |
Clinical Significance
Monitoring EBV DNA levels by quantitative PCR in patients at risk of EBV-associated lymphoproliferative disorders may allow timely recognition of virus reactivation and permit installment of antiviral treatment. Reportable range is 200-2,000,000 copies/mL (2.30 to 6.30 Log copies/mL).